Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Edwards Lifesciences Corp | Director | Common Stock | 70.9K | $6.03M | $85.09 | May 8, 2024 | By Trust |
Envista Holdings Corp | Director | Common Stock | 34.2K | $775K | $22.65 | May 21, 2024 | Direct |
Edwards Lifesciences Corp | Director | Common Stock | 4.05K | $345K | $85.09 | May 8, 2024 | Direct |
ARENA PHARMACEUTICALS INC | Director | Common Stock | 0 | $98.51 | Mar 11, 2022 | By The Gallahue Irrevocable Trust | |
ARENA PHARMACEUTICALS INC | Director | Common Stock | 0 | $98.51 | Mar 11, 2022 | Direct | |
ARENA PHARMACEUTICALS INC | Director | Stock Option (right to buy) | 0 | Mar 11, 2022 | Direct | ||
Edwards Lifesciences Corp | Director | Director Stock Option (Right to Acquire) | 0 | Feb 23, 2024 | Direct | ||
Intersect ENT, Inc. | Director | Common Stock | 0 | $28.25 | May 13, 2022 | Direct | |
Intersect ENT, Inc. | Director | Common Stock | 0 | $28.25 | May 13, 2022 | Indirect | |
Intersect ENT, Inc. | Director | Stock Options (Right to buy) | 0 | $28.25 | May 13, 2022 | Direct |